About this trial
Sleep problems and regulation difficulties are frequent in the child and adolescent psychiatry population. Insomnia and delayed sleep-wake phase disorders (DSPWD) are highly prevalent, and risk factors for developing more severe illness courses and chronic disorders. Pharmacological treatments of sleep disorders dominate even for the youngest patients but are unsupported by long-term data on outcome and side effects. The majority of non-pharmacological treatment options are composite and resource demanding. The investigators will examine the effects and feasibility of the isolated intervention of evening/night use of blue-blocking glasses/real darkness as adjunctive treatment for insomnia and delayed sleep phase disorder in inpatient and outpatient settings for children and adolecents.
Eligibility criteria
Qualifiers
Age 12-18 years, receiving health-care from child and adolescent mental health services at UPA University Hospital of North Norway, Tromsø or BUP Haugesund Hospital, Haugesund
Current Insomnia or DSPD comorbid to one or several pychiatric symptom presentations or diagnoses
Able and willing to provide written informed consent
Participants aged 12-15,9 years also need consent from both parents/carers
Disqualifiers
Not able to comply with protocol for a required minimum of one night
Blindness or severely reduced translucency of both eyes
Known malformation or damage of optical tract blindness
Use of melatonin all formulas that cannot be paused
Trial design
Treatments tested in this trial
- Blue-blocking glasses (BB-glasses) or real darkness from 9 p.m. to desired wake-up time + night mode setting on mobile phone
- Control
Treatment groups
Sponsors and collaborators
Helse Fonna
Lead sponsor
University of Bergen
Collaborator
University of Oslo
Collaborator
University Hospital of North Norway
Collaborator
Helse Vest
Collaborator